Learn about ZMapp, an experimental drug to treat Ebola, in this video from NOVA: Surviving Ebola. ZMapp is not a vaccine; it prevents further spread of the Ebola virus within an infected person. ZMapp is created by injecting plants with a genetically modified virus. This causes the plant cells to produce antibodies for the Ebola virus, which scientists then extract and purify. Currently, this technique has only been used to make a small amount of antibodies and may not be feasible to produce enough medicine to combat the 2013 epidemic. ZMapp has been given to several individuals; however, it is relatively untested, and its safety and efficacy are not known.
Visit the program page here.